Since Lieberman's report in 1975,1 measurement of serum levels of angiotensin I converting enzyme (SACE) is known to have potential value in confirming the diagnosis and estimating the activity of sarcoidosis. On the other hand, in various series of patients with active sarcoidosis the prevalence of increased SACE levels has ranged from 33% to 88%.2 It is also reported that black subjects tend to have higher SACE levels than whites in sarcoidosis. 3 These findings suggest that there may be genetic or racial differences in SACE levels in patients with sarcoidosis.
In normal adults SACE levels can differ greatly from subject to subject by more than five times,' 4 but in a given subject SACE levels remain relatively constant.5 Population-based reference intervals for SACE levels are therefore recognised as having some limitations to detect abnormality because the interindividual variation is greater than the intra-individual variation.' Cambien et al reported familial resemblance of plasma ACE levels in a large family study.7 After cloning of the human endothelial ACE gene,8 a genetic control of plasma ACE levels has been suggested by the identification of an I/D polymorphism of the ACE gene. 9 We have studied the predisposition to sarcoidosis, as well as the genetic regulation of SACE levels, in patients with sarcoidosis and in controls from the point of view of polymorphism of the ACE gene.
Methods

SUBJECTS
Three hundred and forty one healthy unrelated Japanese subjects (179 men) of mean (SD) age 42.5 (11.5) years, recruited from subjects who presented for a medical check-up, were selected as controls for the study. Patients with sarcoidosis and those with any other diseases who were receiving medication such as ACE inhibitors, or on the basis of physical examination, chest radiographs, electrocardiograms, and routine laboratory tests were excluded.
One hundred and three consecutive patients with sarcoidosis (33 men) of mean (SD) age 39.5 (16.4) 
Discussion
We have found a significant association between ACE gene polymorphism and SACE activity in both patients with sarcoidosis and control subjects. This association, and the distribution of the three ACE genotypes in our Japanese population, has led to three important findings. Firstly, allele I was the more frequent and a relative excess of genotype II (46%) was recognised in controls compared with white skinned subjects.9 13 In other words, it is probable that Japanese subjects in general may have genetically lower SACE levels. Secondly, although the exact mechanism by which SACE levels are increased in patients with sarcoidosis has not been elucidated, induction of SACE in patients seems to be considerably regulated by this polymorphism, and the presence or absence of allele D is associated with higher or lower SACE levels in patients withsarcoidosis. Thirdly,thewholereferenceinter- (fig 1) . In particular, the new reference interval improved diagnostic sensitivity from 6% to 60% in patients with genotype II. The variation in distribution of the ACE genotype among races can partly explain the considerable difference found in the incidence of increased SACE levels in patients with sarcoidosis in previous reports. 2 Subgroup analyses of both allele frequencies revealed an excess of allele D in female patients. The presence of allele D -namely, genotype DD plus ID -was associated with a significant increase in the risk for sarcoidosis in women (odds ratio 2.18), whereas no significant association was seen in men. In this regard, Lieberman reported that black patients tend to have higher SACE levels than whites,3 and a definitely increased risk in black American women has also been reported. '4 In fact, allele D has been more frequently recognised in black subjects than in whites.'" On the other hand, the increased frequency of allele I (0.70) has been reported in Chinese,'6 and sarcoidosis is rarely seen in China.'7 These epidemiological findings are consistent with our current finding that genotype DD or ID, which is associated with higher SACE levels, may contribute genetic predisposition to sarcoidosis, at least in women. As this is a limited subgroup population study, we 
